skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Glucose responsive insulin production from human embryonic germ (EG) cell derivatives

Abstract

Type 1 diabetes mellitus subjects millions to a daily burden of disease management, life threatening hypoglycemia and long-term complications such as retinopathy, nephropathy, heart disease, and stroke. Cell transplantation therapies providing a glucose-regulated supply of insulin have been implemented clinically, but are limited by safety, efficacy and supply considerations. Stem cells promise a plentiful and flexible source of cells for transplantation therapies. Here, we show that cells derived from human embryonic germ (EG) cells express markers of definitive endoderm, pancreatic and {beta}-cell development, glucose sensing, and production of mature insulin. These cells integrate functions necessary for glucose responsive regulation of preproinsulin mRNA and expression of insulin C-peptide in vitro. Following transplantation into mice, cells become insulin and C-peptide immunoreactive and produce plasma C-peptide in response to glucose. These findings suggest that EG cell derivatives may eventually serve as a source of insulin producing cells for the treatment of diabetes.

Authors:
 [1];  [2];  [2];  [2];  [2];  [3]
  1. Division of Endocrinology and Metabolism, Johns Hopkins University School of Medicine, 1830 E. Monument Street, Suite 333, Baltimore, MD 21287 (United States)
  2. Department of Gynecology and Obstetrics, Institute for Cell Engineering, Johns Hopkins University School of Medicine, 733 North Broadway, BRB 769, Baltimore, MD 21205 (United States)
  3. Department of Gynecology and Obstetrics, Institute for Cell Engineering, Johns Hopkins University School of Medicine, 733 North Broadway, BRB 769, Baltimore, MD 21205 (United States). E-mail: mshambl1@jhmi.edu
Publication Date:
OSTI Identifier:
20991333
Resource Type:
Journal Article
Resource Relation:
Journal Name: Biochemical and Biophysical Research Communications; Journal Volume: 356; Journal Issue: 3; Other Information: DOI: 10.1016/j.bbrc.2007.03.017; PII: S0006-291X(07)00474-3; Copyright (c) 2007 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA)
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; GENE REGULATION; GLUCOSE; IN VITRO; INSULIN; MICE; PANCREAS; PEPTIDES; STEM CELLS; THERAPY

Citation Formats

Clark, Gregory O., Yochem, Robert L., Axelman, Joyce, Sheets, Timothy P., Kaczorowski, David J., and Shamblott, Michael J.. Glucose responsive insulin production from human embryonic germ (EG) cell derivatives. United States: N. p., 2007. Web. doi:10.1016/j.bbrc.2007.03.017.
Clark, Gregory O., Yochem, Robert L., Axelman, Joyce, Sheets, Timothy P., Kaczorowski, David J., & Shamblott, Michael J.. Glucose responsive insulin production from human embryonic germ (EG) cell derivatives. United States. doi:10.1016/j.bbrc.2007.03.017.
Clark, Gregory O., Yochem, Robert L., Axelman, Joyce, Sheets, Timothy P., Kaczorowski, David J., and Shamblott, Michael J.. Fri . "Glucose responsive insulin production from human embryonic germ (EG) cell derivatives". United States. doi:10.1016/j.bbrc.2007.03.017.
@article{osti_20991333,
title = {Glucose responsive insulin production from human embryonic germ (EG) cell derivatives},
author = {Clark, Gregory O. and Yochem, Robert L. and Axelman, Joyce and Sheets, Timothy P. and Kaczorowski, David J. and Shamblott, Michael J.},
abstractNote = {Type 1 diabetes mellitus subjects millions to a daily burden of disease management, life threatening hypoglycemia and long-term complications such as retinopathy, nephropathy, heart disease, and stroke. Cell transplantation therapies providing a glucose-regulated supply of insulin have been implemented clinically, but are limited by safety, efficacy and supply considerations. Stem cells promise a plentiful and flexible source of cells for transplantation therapies. Here, we show that cells derived from human embryonic germ (EG) cells express markers of definitive endoderm, pancreatic and {beta}-cell development, glucose sensing, and production of mature insulin. These cells integrate functions necessary for glucose responsive regulation of preproinsulin mRNA and expression of insulin C-peptide in vitro. Following transplantation into mice, cells become insulin and C-peptide immunoreactive and produce plasma C-peptide in response to glucose. These findings suggest that EG cell derivatives may eventually serve as a source of insulin producing cells for the treatment of diabetes.},
doi = {10.1016/j.bbrc.2007.03.017},
journal = {Biochemical and Biophysical Research Communications},
number = 3,
volume = 356,
place = {United States},
year = {Fri May 11 00:00:00 EDT 2007},
month = {Fri May 11 00:00:00 EDT 2007}
}